L-Arginine Supplements :
The pharmaceutical compositions of the invention are adapted to the chosen mode of administration, including oral, parenteral. They can therefore be found, for example, capsules, tablets, capsules, oral solutions, injectable, or a form suitable for extended release. The compounds of the invention can be administered at a dose between 0.1 and 1000 mg per day. Preferably, the compounds can be administered at a dose between 1 and 100 mg. The invention finally relates to the use of derivatives of L-Arginine Supplements of formula I as defined above for the preparation of a medicament for the treatment of diseases of the central nervous system and peripheral pathologies of failures gastrointestinal and urinary inflammatory or not, or diseases related to cardiovascular or lung.
No Comments
No comments yet.
Sorry, the comment form is closed at this time.